ATN 113 Specimen Tracking Form: Blood for PBMC in Project PrEPare – an Open Label Demonstration Project and Phase II Safety Study of Pre-exposure Prophylaxis Use Among 15 to 17 Year Old Young Men Who Have Sex With Men (YMSM) in the United States

Data from Specimen Tracking Form: Blood for PBMC [CRF 100] Study Description This pre-exposure prophylaxis (PrEP) demonstration project and phase II safety study aimed to obtain additional data on the safety of emtricitabine/tenofovir (FTC/TDF (Truvada®)). Patterns of use, rates of adherence, and patterns of sexual risk behavior among YMSM (inclusive of transgender women) who were provided with open label FTC/TDF (Truvada®) and information on the safety and efficacy of PrEP from prior studies were evaluated. Furthermore, this project explored the feasibility and acceptability of implementing two different types of efficacious risk reduction interventions prior to the provision of PrEP – Many Men, Many Voices (3MV) and Personalized Cognitive Counseling (PCC). HIV-1 uninfected 15 to 17 year old young men who have sex with men

搜集汇总

背景与挑战

背景概述

该数据集是ATN 113项目中用于追踪PBMC血液样本的标本表格，来源于一项针对15-17岁男男性行为者（YMSM）的PrEP暴露前预防示范和安全II期研究。数据集记录了血液样本的追踪信息，以支持评估FTC/TDF（Truvada）的安全性、使用模式、依从性及性风险行为，并探索两种风险降低干预的可行性。